JP Stock MarketDetailed Quotes

4967 Kobayashi Pharmaceutical

Watchlist
  • 6337.0
  • +164.0+2.66%
20min DelayMarket Closed Dec 27 15:30 JST
494.60BMarket Cap23.63P/E (Static)

Kobayashi Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
-9.16%41.32B
-8.73%36.65B
9.02%36.49B
4.33%173.46B
4.54%54.34B
5.75%45.49B
3.99%40.16B
2.51%33.47B
7.09%166.26B
9.21%51.98B
Cost of revenue
-2.48%19.38B
-0.88%16.85B
9.87%15.53B
4.26%77.08B
4.25%26.07B
6.94%19.88B
4.09%17B
0.95%14.14B
11.21%73.93B
12.49%25.01B
Gross profit
-14.35%21.94B
-14.49%19.81B
8.40%20.95B
4.38%96.38B
4.81%28.27B
4.86%25.61B
3.92%23.16B
3.69%19.33B
4.01%92.33B
6.35%26.97B
Operating expense
-13.22%14.43B
-13.77%15.36B
11.61%15.92B
7.51%70.59B
14.84%21.88B
6.98%16.63B
3.19%17.82B
3.41%14.27B
4.71%65.66B
1.76%19.05B
Staff costs
----
----
----
6.97%15.74B
----
----
----
----
6.79%14.71B
----
Selling and administrative expenses
----
----
----
4.91%33.16B
----
----
----
----
-0.57%31.61B
----
-Selling and marketing expense
----
----
----
4.36%27.74B
----
----
----
----
-0.02%26.58B
----
-General and administrative expense
----
----
----
7.86%5.42B
----
----
----
----
-3.38%5.02B
----
Research and development costs
----
----
----
8.13%9B
----
----
----
----
10.70%8.33B
----
Depreciation and amortization
----
----
----
20.18%3.2B
----
----
----
----
11.32%2.67B
----
-Depreciation
----
----
----
24.46%2.08B
----
----
----
----
8.81%1.67B
----
-Amortization
----
----
----
13.03%1.13B
----
----
----
----
15.78%998M
----
Rent and land expenses
----
----
----
4.04%1.52B
----
----
----
----
7.26%1.46B
----
Other operating expenses
----
----
----
15.70%7.97B
----
----
----
----
17.53%6.88B
----
Operating profit
-16.45%7.5B
-16.89%4.44B
-0.63%5.03B
-3.34%25.78B
-19.29%6.4B
1.14%8.98B
6.41%5.35B
4.46%5.06B
2.31%26.67B
19.28%7.93B
Net non-operating interest income (expenses)
-17.50%33M
-28.30%38M
25.00%65M
176.12%185M
53.85%40M
166.67%40M
430.00%53M
225.00%52M
-40.71%67M
18.18%26M
Non-operating interest income
-25.00%39M
-15.00%51M
23.21%69M
151.76%214M
48.39%46M
173.68%52M
300.00%60M
180.00%56M
-35.11%85M
14.81%31M
Non-operating interest expense
-50.00%6M
85.71%13M
0.00%4M
61.11%29M
20.00%6M
200.00%12M
40.00%7M
0.00%4M
0.00%18M
0.00%5M
Net investment income
-792.75%-478M
-6.68%433M
512.73%227M
-18.78%588M
165.87%110M
-59.41%69M
-21.22%464M
-141.67%-55M
-22.81%724M
-149.55%-167M
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
0
0
890.91%436M
0
0
166.67%44M
1,200.00%44M
Income from associates and other participating interests
Special income (charges)
-794.75%-2.52B
-6,095.71%-4.34B
-3,199.16%-3.93B
33.15%-359M
-56.47%-532M
570.13%362M
-1.45%-70M
-133.33%-119M
-25.76%-537M
-24.54%-340M
Less:Other special charges
700.49%2.46B
10,941.03%4.31B
5,432.86%3.87B
-52.13%146M
83.95%447M
-2,257.89%-410M
-2.50%39M
2,233.33%70M
15,150.00%305M
511.86%243M
Less:Write off
10.42%53M
0.00%31M
8.16%53M
-8.19%213M
-12.37%85M
-17.24%48M
6.90%31M
2.08%49M
-45.41%232M
-70.78%97M
Other non-operating income (expenses)
-23.31%477M
-46.86%93M
21.52%192M
-5.68%930M
-125.25%-25M
19.16%622M
-16.27%175M
1.28%158M
-2.76%986M
312.50%99M
Income before tax
-50.12%5.02B
-88.79%669M
-68.88%1.59B
-1.40%27.56B
-15.29%6.42B
5.92%10.07B
3.56%5.97B
0.00%5.1B
1.14%27.95B
12.40%7.58B
Income tax
-54.30%1.12B
-87.83%208M
-59.03%610M
-8.91%7.22B
-23.04%1.58B
-9.96%2.44B
11.26%1.71B
-8.31%1.49B
0.09%7.93B
7.64%2.06B
Net income
-48.78%3.91B
-89.20%460M
-72.95%976M
1.58%20.34B
-12.39%4.84B
12.26%7.63B
0.73%4.26B
3.89%3.61B
1.56%20.02B
14.28%5.52B
Net income continuous operations
-48.79%3.91B
-89.18%461M
-72.95%976M
1.57%20.34B
-12.40%4.84B
12.25%7.63B
0.76%4.26B
3.89%3.61B
1.56%20.02B
14.28%5.52B
Noncontrolling interests
0
0
1M
0
Net income attributable to the company
-48.81%3.91B
-89.19%460M
-72.95%976M
1.58%20.34B
-12.35%4.84B
12.26%7.63B
0.69%4.26B
3.89%3.61B
1.56%20.02B
14.28%5.52B
Preferred stock dividends
Other under preferred stock dividend
0
0
0
0
0
0
0
0
0
0
Net income attributable to common stockholders
-48.81%3.91B
-89.19%460M
-72.95%976M
1.58%20.34B
-12.35%4.84B
12.26%7.63B
0.69%4.26B
3.89%3.61B
1.56%20.02B
14.28%5.52B
Gross dividend payment
Basic earnings per share
-47.57%52.58
-88.93%6.19
-72.32%13.13
3.29%268.16
-10.53%64.52
14.00%100.29
2.27%55.92
5.71%47.43
2.88%259.63
16.42%72.11
Diluted earnings per share
-47.58%52.5701
-88.93%6.1879
-72.32%13.13
3.30%268.16
-10.53%64.52
13.99%100.2785
2.24%55.9058
5.71%47.43
2.86%259.59
16.42%72.11
Dividend per share
0
0.00%43
0
12.22%101
11.54%58
0
13.16%43
0
8.43%90
13.04%52
Currency Unit
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue -9.16%41.32B-8.73%36.65B9.02%36.49B4.33%173.46B4.54%54.34B5.75%45.49B3.99%40.16B2.51%33.47B7.09%166.26B9.21%51.98B
Cost of revenue -2.48%19.38B-0.88%16.85B9.87%15.53B4.26%77.08B4.25%26.07B6.94%19.88B4.09%17B0.95%14.14B11.21%73.93B12.49%25.01B
Gross profit -14.35%21.94B-14.49%19.81B8.40%20.95B4.38%96.38B4.81%28.27B4.86%25.61B3.92%23.16B3.69%19.33B4.01%92.33B6.35%26.97B
Operating expense -13.22%14.43B-13.77%15.36B11.61%15.92B7.51%70.59B14.84%21.88B6.98%16.63B3.19%17.82B3.41%14.27B4.71%65.66B1.76%19.05B
Staff costs ------------6.97%15.74B----------------6.79%14.71B----
Selling and administrative expenses ------------4.91%33.16B-----------------0.57%31.61B----
-Selling and marketing expense ------------4.36%27.74B-----------------0.02%26.58B----
-General and administrative expense ------------7.86%5.42B-----------------3.38%5.02B----
Research and development costs ------------8.13%9B----------------10.70%8.33B----
Depreciation and amortization ------------20.18%3.2B----------------11.32%2.67B----
-Depreciation ------------24.46%2.08B----------------8.81%1.67B----
-Amortization ------------13.03%1.13B----------------15.78%998M----
Rent and land expenses ------------4.04%1.52B----------------7.26%1.46B----
Other operating expenses ------------15.70%7.97B----------------17.53%6.88B----
Operating profit -16.45%7.5B-16.89%4.44B-0.63%5.03B-3.34%25.78B-19.29%6.4B1.14%8.98B6.41%5.35B4.46%5.06B2.31%26.67B19.28%7.93B
Net non-operating interest income (expenses) -17.50%33M-28.30%38M25.00%65M176.12%185M53.85%40M166.67%40M430.00%53M225.00%52M-40.71%67M18.18%26M
Non-operating interest income -25.00%39M-15.00%51M23.21%69M151.76%214M48.39%46M173.68%52M300.00%60M180.00%56M-35.11%85M14.81%31M
Non-operating interest expense -50.00%6M85.71%13M0.00%4M61.11%29M20.00%6M200.00%12M40.00%7M0.00%4M0.00%18M0.00%5M
Net investment income -792.75%-478M-6.68%433M512.73%227M-18.78%588M165.87%110M-59.41%69M-21.22%464M-141.67%-55M-22.81%724M-149.55%-167M
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets 00890.91%436M00166.67%44M1,200.00%44M
Income from associates and other participating interests
Special income (charges) -794.75%-2.52B-6,095.71%-4.34B-3,199.16%-3.93B33.15%-359M-56.47%-532M570.13%362M-1.45%-70M-133.33%-119M-25.76%-537M-24.54%-340M
Less:Other special charges 700.49%2.46B10,941.03%4.31B5,432.86%3.87B-52.13%146M83.95%447M-2,257.89%-410M-2.50%39M2,233.33%70M15,150.00%305M511.86%243M
Less:Write off 10.42%53M0.00%31M8.16%53M-8.19%213M-12.37%85M-17.24%48M6.90%31M2.08%49M-45.41%232M-70.78%97M
Other non-operating income (expenses) -23.31%477M-46.86%93M21.52%192M-5.68%930M-125.25%-25M19.16%622M-16.27%175M1.28%158M-2.76%986M312.50%99M
Income before tax -50.12%5.02B-88.79%669M-68.88%1.59B-1.40%27.56B-15.29%6.42B5.92%10.07B3.56%5.97B0.00%5.1B1.14%27.95B12.40%7.58B
Income tax -54.30%1.12B-87.83%208M-59.03%610M-8.91%7.22B-23.04%1.58B-9.96%2.44B11.26%1.71B-8.31%1.49B0.09%7.93B7.64%2.06B
Net income -48.78%3.91B-89.20%460M-72.95%976M1.58%20.34B-12.39%4.84B12.26%7.63B0.73%4.26B3.89%3.61B1.56%20.02B14.28%5.52B
Net income continuous operations -48.79%3.91B-89.18%461M-72.95%976M1.57%20.34B-12.40%4.84B12.25%7.63B0.76%4.26B3.89%3.61B1.56%20.02B14.28%5.52B
Noncontrolling interests 001M0
Net income attributable to the company -48.81%3.91B-89.19%460M-72.95%976M1.58%20.34B-12.35%4.84B12.26%7.63B0.69%4.26B3.89%3.61B1.56%20.02B14.28%5.52B
Preferred stock dividends
Other under preferred stock dividend 0000000000
Net income attributable to common stockholders -48.81%3.91B-89.19%460M-72.95%976M1.58%20.34B-12.35%4.84B12.26%7.63B0.69%4.26B3.89%3.61B1.56%20.02B14.28%5.52B
Gross dividend payment
Basic earnings per share -47.57%52.58-88.93%6.19-72.32%13.133.29%268.16-10.53%64.5214.00%100.292.27%55.925.71%47.432.88%259.6316.42%72.11
Diluted earnings per share -47.58%52.5701-88.93%6.1879-72.32%13.133.30%268.16-10.53%64.5213.99%100.27852.24%55.90585.71%47.432.86%259.5916.42%72.11
Dividend per share 00.00%43012.22%10111.54%58013.16%4308.43%9013.04%52
Currency Unit JPYJPYJPYJPYJPYJPYJPYJPYJPYJPY
Accounting Standards NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP
Top JP Stock Gainers
Symbol Price % Chg
Twenty-four seven
7074
290 +33.64%
Alpico Holdings
297A
321 +33.20%
Branding Technology
7067
1338 +28.90%
Estore
4304
1504 +24.92%
Axel Mark
3624
172 +22.86%

See the daily top gainer.